| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FMK | GDSC1000 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | 0.051 | 0.1 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | -0.049 | 0.1 |
| mRNA | Bortezomib | FIMM | pan-cancer | AAC | -0.22 | 0.1 |
| mRNA | Sunitinib | FIMM | pan-cancer | AAC | 0.26 | 0.1 |
| mRNA | 17-AAG | FIMM | pan-cancer | AAC | -0.26 | 0.1 |
| mRNA | Cyclopamine | GDSC1000 | pan-cancer | AAC | 0.077 | 0.1 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | -0.068 | 0.1 |
| mRNA | palmostatin B | CTRPv2 | pan-cancer | AAC | 0.068 | 0.1 |
| mRNA | KU-55933 | CTRPv2 | pan-cancer | AAC | 0.055 | 0.1 |